TELO2

telomere maintenance 2, the group of Armadillo like helical domain containing|TTT complex

Basic information

Region (hg38): 16:1493344-1510457

Links

ENSG00000100726NCBI:9894OMIM:611140HGNC:29099Uniprot:Q9Y4R8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • TELO2-related intellectual disability-neurodevelopmental disorder (Supportive), mode of inheritance: AR
  • TELO2-related intellectual disability-neurodevelopmental disorder (Strong), mode of inheritance: AR
  • TELO2-related intellectual disability-neurodevelopmental disorder (Definitive), mode of inheritance: AR
  • TELO2-related intellectual disability-neurodevelopmental disorder (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
You-Hoover-Fong syndromeARCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Craniofacial; Musculoskeletal; Neurologic27132593

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TELO2 gene.

  • not_provided (433 variants)
  • Inborn_genetic_diseases (173 variants)
  • TELO2-related_intellectual_disability-neurodevelopmental_disorder (32 variants)
  • TELO2-related_disorder (18 variants)
  • not_specified (10 variants)
  • Microcephaly (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TELO2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016111.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
147
clinvar
11
clinvar
160
missense
1
clinvar
9
clinvar
228
clinvar
32
clinvar
11
clinvar
281
nonsense
4
clinvar
1
clinvar
1
clinvar
6
start loss
1
1
frameshift
7
clinvar
3
clinvar
1
clinvar
11
splice donor/acceptor (+/-2bp)
7
clinvar
1
clinvar
8
Total 12 21 233 179 22

Highest pathogenic variant AF is 0.000180755

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TELO2protein_codingprotein_codingENST00000262319 2017114
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.20e-140.8331256770681257450.000270
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3675685441.040.00003795237
Missense in Polyphen105117.320.894991314
Synonymous-1.952942541.160.00001841838
Loss of Function1.932740.20.6720.00000209424

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004260.000392
Ashkenazi Jewish0.00009930.0000992
East Asian0.0009810.000925
Finnish0.000.00
European (Non-Finnish)0.0002890.000273
Middle Eastern0.0009810.000925
South Asian0.0002960.000294
Other0.0001780.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulator of the DNA damage response (DDR). Part of the TTT complex that is required to stabilize protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex is involved in the cellular resistance to DNA damage stresses, like ionizing radiation (IR), ultraviolet (UV) and mitomycin C (MMC). Together with the TTT complex and HSP90 may participate in the proper folding of newly synthesized PIKKs. Promotes assembly, stabilizes and maintains the activity of mTORC1 and mTORC2 complexes, which regulate cell growth and survival in response to nutrient and hormonal signals. May be involved in telomere length regulation. {ECO:0000269|PubMed:12670948, ECO:0000269|PubMed:20810650}.;
Disease
DISEASE: You-Hoover-Fong syndrome (YHFS) [MIM:616954]: A syndrome characterized by severe global developmental delay, intellectual disability, dysmorphic facial features, microcephaly, abnormal movements, congenital heart disease comprising developmental abnormalities of the great vessels, and abnormal auditory and visual function. The transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:27132593}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Fanconi anemia pathway - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Steatosis AOP (Consensus)

Recessive Scores

pRec
0.108

Intolerance Scores

loftool
0.217
rvis_EVS
0.42
rvis_percentile_EVS
76.68

Haploinsufficiency Scores

pHI
0.281
hipred
Y
hipred_score
0.743
ghis
0.524

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.643

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Telo2
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
telomere maintenance;regulation of TOR signaling;protein stabilization;positive regulation of protein serine/threonine kinase activity;positive regulation of TORC1 signaling;positive regulation of TORC2 signaling
Cellular component
nuclear chromosome, telomeric region;nucleus;cytoplasm;cytosol;membrane;nuclear body;TORC1 complex;TORC2 complex;nuclear periphery;ASTRA complex
Molecular function
protein binding;protein kinase binding;protein-containing complex scaffold activity;telomeric DNA binding;protein-containing complex binding;Hsp90 protein binding